Topiramate

Topiramate has evidence for reducing drinking in alcohol use disorder, often through off-label prescribing. Its possible benefits need to be weighed against effects on thinking, daily functioning and other health risks.

Topiramate is used for epilepsy and migraine prevention and is also considered in some alcohol-treatment plans. Alcohol-use-disorder prescribing is off-label in settings including New Zealand. Off-label means the use falls outside the product's approved indication; it does not, by itself, mean either proven suitability or lack of evidence.

Research supports benefit for some drinking outcomes, but unwanted effects can matter greatly. If physical alcohol dependence may be present, obtain medical advice before suddenly stopping or sharply reducing drinking. Problems with concentration, memory or finding words, tiredness, tingling and appetite changes deserve clinical review. Reducing drinking while struggling to think or work clearly is a treatment trade-off that should be discussed.

Sudden blurred vision or eye pain needs urgent medical assessment because topiramate can cause a serious eye problem. Sudden confusion needs immediate medical help. A new rash or blisters needs urgent medical advice. New suicidal thoughts need prompt support and clinical attention; immediate danger requires emergency help.

Topiramate can harm a developing baby during pregnancy. Pregnancy possibility, plans and contraception need discussion with the prescriber. If pregnancy occurs, contact them promptly. Do not start, change or abruptly stop topiramate by yourself; stopping can create seizure risk even for someone without a previous seizure history.

Full access is needed to read this Topic's articles.